(Q45170206)

English

Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice

scientific article published on 18 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice (English)

1 reference

Europe PubMed Central

10 December 2017

Alpha-L-iduronidase

1 reference

GOA release 2020-03-11

mucopolysaccharidosis I

1 reference

based on heuristic

inferred from title

author name string

Sarah Chung

1

1 reference

Europe PubMed Central

10 December 2017

Xiucui Ma

2

1 reference

Europe PubMed Central

10 December 2017

Yuli Liu

3

1 reference

Europe PubMed Central

10 December 2017

David Lee

4

1 reference

Europe PubMed Central

10 December 2017

Mindy Tittiger

5

1 reference

Europe PubMed Central

10 December 2017

Katherine P Ponder

6

1 reference

Europe PubMed Central

10 December 2017

publication date

18 September 2006

1 reference

Europe PubMed Central

10 December 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

10 December 2017

90

1 reference

Europe PubMed Central

10 December 2017

2

1 reference

Europe PubMed Central

10 December 2017

181-192

1 reference

Europe PubMed Central

10 December 2017

An update on the frequency of mucopolysaccharide syndromes in British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Enzyme replacement and enhancement therapies for lysosomal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Enzyme replacement therapy in feline mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Enzyme replacement in a canine model of Hurler syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Gene therapy progress and prospects: gene therapy of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Abnormal immune function in vivo in a murine model of lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Frizzled9 protein is regionally expressed in the developing medial cortical wall and the cells derived from this region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.08.001

7 January 2021

Identifiers

10.1016/J.YMGME.2006.08.001

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45170206&oldid=2068852423"